🌟🌟🌟Next to AI and Bitcoin,

🌟🌟🌟Next to AI and Bitcoin, Obesity Drugs are big this year. $Viking Therapeutics(VKTX)$ said on Tuesday this week that its experimental drug helped patients with obesity lose nearly 15% of their body weight. As a result Viking Therapeutics Share price has skyrocketed more than 100% in the past 5 days.

Viking Therapeutics is hoping for a share of the potential USD 100 billion obesity treatment market currently dominated by $Eli Lilly(LLY)$ and $Novo-Nordisk A/S(NVO)$ .

@虎港通：【🎁有獎話題】減肥神葯概念股暴漲！除咗AI幣股，減肥葯也將主導24年股市？

Is VKTX Heading to $100?

Shares of biopharmaceutical stock VKTX soared about 25% . The company announced early positive study results for its oral weight-loss drug. VKTX said the drug's Phase 1 clinical trial focused on evaluating its safety and significantly exceed market expectations. ---------------- Are weight loss drugs good investing choices? Will you add weight loss drugs as they continue to hit new records?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

不死鸟.
03-01
不死鸟.
👌
- koolgal:
  Best of luck 🍀🍀🍀
- koolgal:
  May you have a wonderful weekend 🌈🌈🌈
- koolgal:
  Thanks my friend 😍😍😍

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":279578258649296,"tweetId":"279578258649296","gmtCreate":1709277872938,"gmtModify":1711524370764,"author":{"id":3559581955535845,"authorId":3559581955535845,"authorIdStr":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"userType":2,"introduction":"Be Extraordinary Is My Motto In Life Because The Best Is Yet To Be!","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"c4ee29b388ff41cc8462b3b7ea00d1e2-1","templateUuid":"c4ee29b388ff41cc8462b3b7ea00d1e2","name":"Monthly Top Contributor","description":"Top 3 Contributors with the most and best Editor's Picks every month","bigImgUrl":"https://static.tigerbbs.com/b0cad6192443c33dca826a001250fbd4","smallImgUrl":"https://static.tigerbbs.com/5ccd98c646815ce7610b0df338e060cc","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.02","individualDisplayEnabled":0},"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.02","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"starInvestorFlag":true,"starInvestorFollowerNum":366,"starInvestorOrderShareNum":18,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":15.24,"showRor":true,"winRationPercentage":4.8},"themes":[{"themeId":"62983a96987c49e5ab9a76d137efd550","categoryId":"7a15628ce2174325bddc6229505e0d70","name":"Is VKTX Heading to $100?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":62983a96987c49e5ab9a76d137efd550}&rnconfig={\"headerBarHidden\": true}","description":"Shares of biopharmaceutical stock VKTX soared about 25% . The company announced early positive study results for its oral weight-loss drug. \nVKTX said the drug's Phase 1 clinical trial focused on evaluating its safety and significantly exceed market expectations.\n----------------\nAre weight loss drugs good investing choices?\nWill you add weight loss drugs as they continue to hit new records?","image":"https://community-static.tradeup.com/news/54e8a559470eb200009ddc15b793c8a7"}],"images":[],"coverImages":[],"html":"<html><head></head><body>🌟🌟🌟Next to AI and Bitcoin, Obesity Drugs are big this year.&nbsp;<a href=\"https://ttm.financial/S/VKTX\">$Viking Therapeutics(VKTX)$ </a> said on Tuesday this week that its experimental drug helped patients with obesity lose nearly 15% of their body weight.&nbsp; As a result Viking Therapeutics Share price has skyrocketed more than 100% in the past 5 days.&nbsp;\nViking Therapeutics is hoping for a share of the potential USD 100 billion obesity treatment market currently dominated by&nbsp;<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$ </a> and&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>.</body></html>","htmlText":"<html><head></head><body>🌟🌟🌟Next to AI and Bitcoin, Obesity Drugs are big this year.&nbsp;<a href=\"https://ttm.financial/S/VKTX\">$Viking Therapeutics(VKTX)$ </a> said on Tuesday this week that its experimental drug helped patients with obesity lose nearly 15% of their body weight.&nbsp; As a result Viking Therapeutics Share price has skyrocketed more than 100% in the past 5 days.&nbsp;\nViking Therapeutics is hoping for a share of the potential USD 100 billion obesity treatment market currently dominated by&nbsp;<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$ </a> and&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>.</body></html>","text":"🌟🌟🌟Next to AI and Bitcoin, Obesity Drugs are big this year. $Viking Therapeutics(VKTX)$ said on Tuesday this week that its experimental drug helped patients with obesity lose nearly 15% of their body weight. As a result Viking Therapeutics Share price has skyrocketed more than 100% in the past 5 days. Viking Therapeutics is hoping for a share of the potential USD 100 billion obesity treatment market currently dominated by $Eli Lilly(LLY)$ and $Novo-Nordisk A/S(NVO)$ .","highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/279578258649296","repostId":279540507521144,"repostType":1,"repost":{"magic":2,"id":279540507521144,"tweetId":"279540507521144","gmtCreate":1709274822578,"gmtModify":1709277002684,"author":{"id":4134821074118532,"authorId":4134821074118532,"authorIdStr":"4134821074118532","name":"虎港通","avatar":"https://community-static.tradeup.com/news/6ace760ebb226aa228910fadd6516856","vip":2,"userType":2,"introduction":"香港本地熱點內容第一時間get!","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.02","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/cee165370947ae11c81112f5f3f67c1c","width":"830","height":"727"},{"img":"https://community-static.tradeup.com/news/7d8c5d7d8cd217bfe68cb84b1d3b68d7","width":"815","height":"543"},{"img":"https://community-static.tradeup.com/news/a0b6b160dcbfbd37c490fc3d667df723","width":"779","height":"547"},{"img":"https://community-static.tradeup.com/news/b597f5542d2ead9bec5c88f75044c292","width":"487","height":"366"},{"img":"https://community-static.tradeup.com/news/66c56df2bd2d70fa6054dacb7ef62797","width":"423","height":"423"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/7d8c5d7d8cd217bfe68cb84b1d3b68d7","width":"815","height":"543"},{"img":"https://community-static.tradeup.com/news/cee165370947ae11c81112f5f3f67c1c","width":"830","height":"727"},{"img":"https://community-static.tradeup.com/news/b597f5542d2ead9bec5c88f75044c292","width":"487","height":"366"}],"title":"【🎁有獎話題】減肥神葯概念股暴漲！除咗AI幣股，減肥葯也將主導24年股市？","html":"<html><head></head><body>Hello小虎們，2023年以來，AI狂潮席捲全球金融市場，在這樣的環境下，大家似乎也忘記了還有一個明星領域同樣也引起了大家的關注——減肥藥。[Cool]最近，又一款減肥藥來了，除了AI幣股外，減肥藥也將主導24年股市嗎？一起來跟虎港通看看吧~~~[Happy]<h4 id=\"id_339379341\">又一款減肥藥來了？</h4>當地時間2月27日，美國生物科技公司Viking Therapeutics，宣佈其在研GLP-1/GIP雙靶點藥物VK2735的二期臨牀試驗取得了積極結果，肥胖患者在經過13周的治療之後，平均體重減輕高達13.1%。在該消息發佈後，該公司股價當天大漲超120%！[Miser]<img src=\"https://community-static.tradeup.com/news/cee165370947ae11c81112f5f3f67c1c\" tg-width=\"830\" tg-height=\"727\">Viking Therapeutics股價大漲2015年，Viking Therapeutics公司在納斯達克上市，根據市場數據統計，從2022年至今以來，該公司的股價累計漲幅達到23.8倍，同期的禮來、諾和諾德漲幅分別為2.11倍、1.43倍。漲幅之大的原因也不能理解，公司踏上了減肥藥賽道的風口。[Grin]<img src=\"https://community-static.tradeup.com/news/7d8c5d7d8cd217bfe68cb84b1d3b68d7\" tg-width=\"815\" tg-height=\"543\">Viking Therapeutics在納斯達克上市 圖源：公司官網據悉，該公司所研發的VK2735是被認為可以和“減肥藥雙雄”中的禮來的替爾泊肽、諾和諾德的司美格魯肽競爭市場。[Surprised]據悉，Viking公司所研發的VK2735不僅針對胰高血糖素樣肽1（GLP-1），同樣還針對葡萄糖依賴性胰島素促泌肽（GIP）受體，是一種雙重激動劑。該公司最新公佈的數據是來自於二期臨牀雙盲試驗結果，成功達到試驗設計的主要終點和所有次要的終點。主要評價終點是比較用藥組與安慰劑組，在13週期內的體重下降百分比。[Great]Viking公司進一步介紹，接受該藥物治療的肥胖患者中，88%的體重減輕了至少10%，而安慰劑組的體重減輕了4%。而且，試驗結束時體重減輕也沒有達到穩定水平，這意味着在藥量和時間上還需要進一步研究。該公司首席執行官Brian Lian表示，鑑於所有劑量組都沒有觀察到平臺期的情況，表明延長給藥週期可能會實現進一步的體重降低。公司期待在今年晚些時候將這種新的療法進行進一步的研究和開發。並且他們計劃與美國食品藥品監督管理局（FDA）會面，討論VK2735的下一步開發計劃。<img src=\"https://community-static.tradeup.com/news/a0b6b160dcbfbd37c490fc3d667df723\" tg-width=\"779\" tg-height=\"547\">Viking公司所研發的VK2735研究數據 圖源：澎湃新聞<h4 id=\"id_4012454199\">禮來、諾和諾德會如何應對呢？</h4>除了AI外，減肥藥熱度也在2023年開始一度走紅，該產業蘊含的市場空間巨大，目前也成為了醫藥領域的明星賽道。根據世界肥胖聯盟的數據顯示，全球肥胖和超重的趨勢正在逐漸攀升，並且預計到2035年，全球將有超過40億人處於超重或肥胖的身體狀態。[OMG]面對來勢洶洶的新款減肥藥VK2735，在Viking公司發佈臨牀試驗數據後，禮來和諾和諾德股價有所下跌，他們又應該如何應對呢？[Doubt]實際上，這兩家減肥藥巨頭一直在GLP-1減肥賽道上不斷前進：當地時間2月13日，美國生物技術公司 BioAge Labs宣佈完成了1.7億美元的孖展，而這項資金主要是用於旗下Azelaprag與禮來公司的替爾泊肽（Tirzepatide）聯合治療肥胖的2期臨牀試驗。[Onlooker]根據BioAge公司介紹，Azelaprag是一種模仿Apelin活動的藥物，Apelin是在人體運動後釋放的物質，有助於調節新陳代謝，促進肌肉再生。BioAge公司此前對227名65歲以及年齡更大的老年人進行了臨牀試驗。實驗結果顯示，這種藥物可以“顯著”預防老年人的肌肉萎縮。而禮來希望自家的減肥藥能夠達到更好的效果：可以掉脂肪，但不掉肌肉。[Yummy]而諾和諾德在此前的財報中也表示，在GLP-1藥物供不應求的大背景下，諾和諾德將選擇繼續加碼投資產能建設。不僅如此，大股東諾和控股也將以115億美元全現金交易收購美國另一家制藥公司康泰倫特，加上債務部分，這筆收購案的總價值將達到165億美元。這次的收購也讓諾和諾德獲得康泰倫特旗下的三個灌裝工廠，這也將有助於公司後期提高包括GLP-1減肥藥Wegovy在內的產能。[Serious]<img src=\"https://community-static.tradeup.com/news/b597f5542d2ead9bec5c88f75044c292\" tg-width=\"487\" tg-height=\"366\">小虎們，除了AI幣股，你認為減肥藥會主導24年股市嗎？[YoYo]🎁評論即可得獎品如下噢~🐯對以下帖子的所有有效評論都將收到5個老虎硬幣。🐯前10名和後10名有合格評論的小虎將獲得另一個10個老虎硬幣。🐯前5名最受歡迎和高質量的評論將獲得另一個15虎硬幣。<img src=\"https://community-static.tradeup.com/news/66c56df2bd2d70fa6054dacb7ef62797\" tg-width=\"423\" tg-height=\"423\"></body></html>","htmlText":"<html><head></head><body>Hello小虎們，2023年以來，AI狂潮席捲全球金融市場，在這樣的環境下，大家似乎也忘記了還有一個明星領域同樣也引起了大家的關注——減肥藥。[Cool]最近，又一款減肥藥來了，除了AI幣股外，減肥藥也將主導24年股市嗎？一起來跟虎港通看看吧~~~[Happy]<h4 id=\"id_339379341\">又一款減肥藥來了？</h4>當地時間2月27日，美國生物科技公司Viking Therapeutics，宣佈其在研GLP-1/GIP雙靶點藥物VK2735的二期臨牀試驗取得了積極結果，肥胖患者在經過13周的治療之後，平均體重減輕高達13.1%。在該消息發佈後，該公司股價當天大漲超120%！[Miser]<img src=\"https://community-static.tradeup.com/news/cee165370947ae11c81112f5f3f67c1c\" tg-width=\"830\" tg-height=\"727\">Viking Therapeutics股價大漲2015年，Viking Therapeutics公司在納斯達克上市，根據市場數據統計，從2022年至今以來，該公司的股價累計漲幅達到23.8倍，同期的禮來、諾和諾德漲幅分別為2.11倍、1.43倍。漲幅之大的原因也不能理解，公司踏上了減肥藥賽道的風口。[Grin]<img src=\"https://community-static.tradeup.com/news/7d8c5d7d8cd217bfe68cb84b1d3b68d7\" tg-width=\"815\" tg-height=\"543\">Viking Therapeutics在納斯達克上市 圖源：公司官網據悉，該公司所研發的VK2735是被認為可以和“減肥藥雙雄”中的禮來的替爾泊肽、諾和諾德的司美格魯肽競爭市場。[Surprised]據悉，Viking公司所研發的VK2735不僅針對胰高血糖素樣肽1（GLP-1），同樣還針對葡萄糖依賴性胰島素促泌肽（GIP）受體，是一種雙重激動劑。該公司最新公佈的數據是來自於二期臨牀雙盲試驗結果，成功達到試驗設計的主要終點和所有次要的終點。主要評價終點是比較用藥組與安慰劑組，在13週期內的體重下降百分比。[Great]Viking公司進一步介紹，接受該藥物治療的肥胖患者中，88%的體重減輕了至少10%，而安慰劑組的體重減輕了4%。而且，試驗結束時體重減輕也沒有達到穩定水平，這意味着在藥量和時間上還需要進一步研究。該公司首席執行官Brian Lian表示，鑑於所有劑量組都沒有觀察到平臺期的情況，表明延長給藥週期可能會實現進一步的體重降低。公司期待在今年晚些時候將這種新的療法進行進一步的研究和開發。並且他們計劃與美國食品藥品監督管理局（FDA）會面，討論VK2735的下一步開發計劃。<img src=\"https://community-static.tradeup.com/news/a0b6b160dcbfbd37c490fc3d667df723\" tg-width=\"779\" tg-height=\"547\">Viking公司所研發的VK2735研究數據 圖源：澎湃新聞<h4 id=\"id_4012454199\">禮來、諾和諾德會如何應對呢？</h4>除了AI外，減肥藥熱度也在2023年開始一度走紅，該產業蘊含的市場空間巨大，目前也成為了醫藥領域的明星賽道。根據世界肥胖聯盟的數據顯示，全球肥胖和超重的趨勢正在逐漸攀升，並且預計到2035年，全球將有超過40億人處於超重或肥胖的身體狀態。[OMG]面對來勢洶洶的新款減肥藥VK2735，在Viking公司發佈臨牀試驗數據後，禮來和諾和諾德股價有所下跌，他們又應該如何應對呢？[Doubt]實際上，這兩家減肥藥巨頭一直在GLP-1減肥賽道上不斷前進：當地時間2月13日，美國生物技術公司 BioAge Labs宣佈完成了1.7億美元的孖展，而這項資金主要是用於旗下Azelaprag與禮來公司的替爾泊肽（Tirzepatide）聯合治療肥胖的2期臨牀試驗。[Onlooker]根據BioAge公司介紹，Azelaprag是一種模仿Apelin活動的藥物，Apelin是在人體運動後釋放的物質，有助於調節新陳代謝，促進肌肉再生。BioAge公司此前對227名65歲以及年齡更大的老年人進行了臨牀試驗。實驗結果顯示，這種藥物可以“顯著”預防老年人的肌肉萎縮。而禮來希望自家的減肥藥能夠達到更好的效果：可以掉脂肪，但不掉肌肉。[Yummy]而諾和諾德在此前的財報中也表示，在GLP-1藥物供不應求的大背景下，諾和諾德將選擇繼續加碼投資產能建設。不僅如此，大股東諾和控股也將以115億美元全現金交易收購美國另一家制藥公司康泰倫特，加上債務部分，這筆收購案的總價值將達到165億美元。這次的收購也讓諾和諾德獲得康泰倫特旗下的三個灌裝工廠，這也將有助於公司後期提高包括GLP-1減肥藥Wegovy在內的產能。[Serious]<img src=\"https://community-static.tradeup.com/news/b597f5542d2ead9bec5c88f75044c292\" tg-width=\"487\" tg-height=\"366\">小虎們，除了AI幣股，你認為減肥藥會主導24年股市嗎？[YoYo]🎁評論即可得獎品如下噢~🐯對以下帖子的所有有效評論都將收到5個老虎硬幣。🐯前10名和後10名有合格評論的小虎將獲得另一個10個老虎硬幣。🐯前5名最受歡迎和高質量的評論將獲得另一個15虎硬幣。<img src=\"https://community-static.tradeup.com/news/66c56df2bd2d70fa6054dacb7ef62797\" tg-width=\"423\" tg-height=\"423\"></body></html>","text":"Hello小虎們，2023年以來，AI狂潮席捲全球金融市場，在這樣的環境下，大家似乎也忘記了還有一個明星領域同樣也引起了大家的關注——減肥藥。[Cool] 最近，又一款減肥藥來了，除了AI幣股外，減肥藥也將主導24年股市嗎？一起來跟虎港通看看吧~~~[Happy] 又一款減肥藥來了？ 當地時間2月27日，美國生物科技公司Viking Therapeutics，宣佈其在研GLP-1/GIP雙靶點藥物VK2735的二期臨牀試驗取得了積極結果，肥胖患者在經過13周的治療之後，平均體重減輕高達13.1%。在該消息發佈後，該公司股價當天大漲超120%！[Miser] Viking Therapeutics股價大漲 2015年，Viking Therapeutics公司在納斯達克上市，根據市場數據統計，從2022年至今以來，該公司的股價累計漲幅達到23.8倍，同期的禮來、諾和諾德漲幅分別為2.11倍、1.43倍。漲幅之大的原因也不能理解，公司踏上了減肥藥賽道的風口。[Grin] Viking Therapeutics在納斯達克上市 圖源：公司官網 據悉，該公司所研發的VK2735是被認為可以和“減肥藥雙雄”中的禮來的替爾泊肽、諾和諾德的司美格魯肽競爭市場。[Surprised] 據悉，Viking公司所研發的VK2735不僅針對胰高血糖素樣肽1（GLP-1），同樣還針對葡萄糖依賴性胰島素促泌肽（GIP）受體，是一種雙重激動劑。該公司最新公佈的數據是來自於二期臨牀雙盲試驗結果，成功達到試驗設計的主要終點和所有次要的終點。主要評價終點是比較用藥組與安慰劑組，在13週期內的體重下降百分比。[Great] Viking公司進一步介紹，接受該藥物治療的肥胖患者中，88%的體重減輕了至少10%，而安慰劑組的體重減輕了4%。而且，試驗結束時體重減輕也沒有達到穩定水平，這意味着在藥量和時間上還需要進一步研究。該公司首席執行官Brian Lian表示，鑑於所有劑量組都沒有觀察到平臺期的情況，表明延長給藥週期可能會實現進一步的體重降低。公司期待在今年晚些時候將這種新的療法進行進一步的研究和開發。並且他們計劃與美國食品藥品監督管理局（FDA）會面，討論VK2735的下一步開發計劃。 Viking公司所研發的VK2735研究數據 圖源：澎湃新聞 禮來、諾和諾德會如何應對呢？ 除了AI外，減肥藥熱度也在2023年開始一度走紅，該產業蘊含的市場空間巨大，目前也成為了醫藥領域的明星賽道。根據世界肥胖聯盟的數據顯示，全球肥胖和超重的趨勢正在逐漸攀升，並且預計到2035年，全球將有超過40億人處於超重或肥胖的身體狀態。[OMG] 面對來勢洶洶的新款減肥藥VK2735，在Viking公司發佈臨牀試驗數據後，禮來和諾和諾德股價有所下跌，他們又應該如何應對呢？[Doubt] 實際上，這兩家減肥藥巨頭一直在GLP-1減肥賽道上不斷前進： 當地時間2月13日，美國生物技術公司 BioAge Labs宣佈完成了1.7億美元的孖展，而這項資金主要是用於旗下Azelaprag與禮來公司的替爾泊肽（Tirzepatide）聯合治療肥胖的2期臨牀試驗。[Onlooker] 根據BioAge公司介紹，Azelaprag是一種模仿Apelin活動的藥物，Apelin是在人體運動後釋放的物質，有助於調節新陳代謝，促進肌肉再生。BioAge公司此前對227名65歲以及年齡更大的老年人進行了臨牀試驗。實驗結果顯示，這種藥物可以“顯著”預防老年人的肌肉萎縮。而禮來希望自家的減肥藥能夠達到更好的效果：可以掉脂肪，但不掉肌肉。[Yummy] 而諾和諾德在此前的財報中也表示，在GLP-1藥物供不應求的大背景下，諾和諾德將選擇繼續加碼投資產能建設。不僅如此，大股東諾和控股也將以115億美元全現金交易收購美國另一家制藥公司康泰倫特，加上債務部分，這筆收購案的總價值將達到165億美元。這次的收購也讓諾和諾德獲得康泰倫特旗下的三個灌裝工廠，這也將有助於公司後期提高包括GLP-1減肥藥Wegovy在內的產能。[Serious] 小虎們，除了AI幣股，你認為減肥藥會主導24年股市嗎？[YoYo] 🎁評論即可得獎品如下噢~ 🐯對以下帖子的所有有效評論都將收到5個老虎硬幣。 🐯前10名和後10名有合格評論的小虎將獲得另一個10個老虎硬幣。 🐯前5名最受歡迎和高質量的評論將獲得另一個15虎硬幣。","highlighted":2,"essential":2,"paper":2,"link":"https://ttm.financial/post/279540507521144","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":[],"verified":2,"subType":2,"readableState":1,"subTypeObject":{"tweetId":279540507521144,"totalAmount":500,"balance":0,"end":true,"deadline":1709447622566,"description":"235 tiger-coins have been distributed to 38 participants","remainingNumber":62},"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":3047,"xxTargetLangEnum":"ZH_HK"},"isVote":1,"tweetType":1,"viewCount":665,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["VKTX","NVO","LLY"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":401,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":279615708659776,"gmtCreate":1709287003007,"gmtModify":1709287010917,"authorId":4094536006197120,"author":{"id":4094536006197120,"authorId":4094536006197120,"name":"不死鸟.","avatar":"https://static.tigerbbs.com/58aa91ee114515837a7c24d97a1ac173","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":279578258649296,"type":1,"supId":0,"prevId":0,"content":"👌","text":"👌","html":"👌","likeSize":1,"commentSize":3,"subComments":[{"id":279810985033936,"gmtCreate":1709334690915,"gmtModify":1709334697047,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"currentWearingBadge":{"badgeId":"c4ee29b388ff41cc8462b3b7ea00d1e2-1","templateUuid":"c4ee29b388ff41cc8462b3b7ea00d1e2","name":"Monthly Top Contributor","description":"Top 3 Contributors with the most and best Editor's Picks every month","bigImgUrl":"https://static.tigerbbs.com/b0cad6192443c33dca826a001250fbd4","smallImgUrl":"https://static.tigerbbs.com/5ccd98c646815ce7610b0df338e060cc","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.02","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2003},"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.02","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":279578258649296,"type":1,"supId":279615708659776,"prevId":0,"content":"Best of luck 🍀🍀🍀","text":"Best of luck 🍀🍀🍀","html":"Best of luck 🍀🍀🍀"},{"id":279810950303952,"gmtCreate":1709334682435,"gmtModify":1709334690433,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"currentWearingBadge":{"badgeId":"c4ee29b388ff41cc8462b3b7ea00d1e2-1","templateUuid":"c4ee29b388ff41cc8462b3b7ea00d1e2","name":"Monthly Top Contributor","description":"Top 3 Contributors with the most and best Editor's Picks every month","bigImgUrl":"https://static.tigerbbs.com/b0cad6192443c33dca826a001250fbd4","smallImgUrl":"https://static.tigerbbs.com/5ccd98c646815ce7610b0df338e060cc","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.02","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2003},"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.02","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":279578258649296,"type":1,"supId":279615708659776,"prevId":0,"content":"May you have a wonderful weekend 🌈🌈🌈","text":"May you have a wonderful weekend 🌈🌈🌈","html":"May you have a wonderful weekend 🌈🌈🌈"},{"id":279810133709096,"gmtCreate":1709334672679,"gmtModify":1709334685241,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"currentWearingBadge":{"badgeId":"c4ee29b388ff41cc8462b3b7ea00d1e2-1","templateUuid":"c4ee29b388ff41cc8462b3b7ea00d1e2","name":"Monthly Top Contributor","description":"Top 3 Contributors with the most and best Editor's Picks every month","bigImgUrl":"https://static.tigerbbs.com/b0cad6192443c33dca826a001250fbd4","smallImgUrl":"https://static.tigerbbs.com/5ccd98c646815ce7610b0df338e060cc","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.02","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2003},"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.02","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":279578258649296,"type":1,"supId":279615708659776,"prevId":0,"content":"Thanks my friend 😍😍😍","text":"Thanks my friend 😍😍😍","html":"Thanks my friend 😍😍😍"}],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/279578258649296"}